Using gastric ultrasound to improve airway management in patients on GLP-1 medications
Official title: Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)
Run by Clinica Universidad de Navarra, Universidad de Navarra · NCT06666049 · Data updated 2026-11-12
This study is testing if using ultrasound to check stomach contents can help doctors manage the airways of patients on GLP-1 medications before surgery to lower the risk of aspiration pneumonia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 39 (estimated) |
| Sponsor | Clinica Universidad de Navarra, Universidad de Navarra Academic / other |
| Locations | 2 sites (Madrid, Madrid and 1 other locations) |
| Status | Recruiting |
| Started | October 21, 2024 |
| Main results expected | November 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06666049 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years taking GLP-1 analog medications and classified as ASA I-III.
✕Probably not a fit
Patients with a history of esophagogastric pathology, previous abdominal surgery, or those on medications affecting gastric emptying may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the use of gastric ultrasonography performed by trained anesthesiologists to assess gastric content in patients taking GLP-1 receptor agonists prior to scheduled surgery. The aim is to determine if this technique can help make informed clinical decisions regarding airway management and reduce the risk of aspiration pneumonia. Eligible participants include adults over 18 years who are undergoing surgery after a fasting period of 6 to 8 hours. The study will exclude individuals with certain gastrointestinal conditions or those on medications that affect gastric emptying.
Why it matters
Potential benefit: If successful, this approach could enhance patient safety by reducing the risk of aspiration pneumonia during surgery.
How similar studies have gone: While the use of gastric ultrasound in this context is relatively novel, similar studies have shown promise in improving airway management outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults patients ,ASA I-III, taking GLP-1 analog medications, undergoing scheduled surgery. Exclusion Criteria: 1. \- History of esophagogastric pathology or previous abdominal surgery. 2. \- Hiatal hernia/gastroesophageal reflux disease. 3. \- Autonomic nervous system disorders. 4. \- Neurological or neuromuscular diseases. 5. \- Use of medications/drugs that affect autonomic regulation and delay gastric emptying (opioids) or potentiate it (prokinetics). 6. \- Pregnancy. 7. \- Presence of arrhythmias.
Where it's running
-
Clinica Universidad Navarra
Madrid, Madrid, Spain Recruiting -
CAUSA Salamanca
Salamanca, Spain Recruiting
Study contacts
- Study coordinator: Carlos Puga Carrasco, MD
- Email: cpuga@unav.es
- Phone: 0034913531920
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using bronchoscopy to treat aspiration pneumonia in the emergency department
This study is testing if using a special camera to clear mucus from the lungs helps people with aspiration pneumonia in the emergency department feel better compared to the usual method.
-
Assessing gastric volume and emptying in pediatric surgery patients
This study tests if using ultrasound to measure stomach size and how quickly it empties is reliable for kids having surgery, compared to a standard test, to help keep them safe during anesthesia.
-
Esophagus and stomach movement problems and aspiration risk in children with neurologic impairment
This trial will test prucalopride versus famotidine to see which better reduces coughing, choking, and other aspiration-associated symptoms in tube-fed children ages 5–21 with neurologic impairment.
-
Best Care for Acute Stroke in General Wards
A nurse-led program called BEST CARE ICTUS_HC is tested in hospitals without Stroke Units to see if it reduces stroke complications and helps recovery after an acute ischemic or hemorrhagic stroke.
-
MiniLung petite kit for neonates and infants with severe respiratory or cardiac failure
We will test whether the MiniLung petite kit with the Xenios console safely improves oxygenation, removes CO2, and stabilizes circulation in newborns and young infants (2–8 kg) with severe respiratory or cardiopulmonary failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.